<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Sci Data</journal-id>
    <journal-id journal-id-type="iso-abbrev">Sci Data</journal-id>
    <journal-title-group>
      <journal-title>Scientific Data</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2052-4463</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7335193</article-id>
    <article-id pub-id-type="publisher-id">547</article-id>
    <article-id pub-id-type="doi">10.1038/s41597-020-0547-y</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Analysis</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Probabilistic identification of saccharide moieties in biomolecules and their protein complexes</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4566-0582</contrib-id>
        <name>
          <surname>Dashti</surname>
          <given-names>Hesam</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Westler</surname>
          <given-names>William M.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wedell</surname>
          <given-names>Jonathan R.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Demler</surname>
          <given-names>Olga V.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Eghbalnia</surname>
          <given-names>Hamid R.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Markley</surname>
          <given-names>John L.</given-names>
        </name>
        <address>
          <email>jmarkley@wisc.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6283-0980</contrib-id>
        <name>
          <surname>Mora</surname>
          <given-names>Samia</given-names>
        </name>
        <address>
          <email>smora@bwh.harvard.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0378 8294</institution-id><institution-id institution-id-type="GRID">grid.62560.37</institution-id><institution>Center for Lipid Metabolomics, Division of Preventive Medicine, Department of Medicine, </institution><institution>Brigham and Women’s Hospital and Harvard Medical School, </institution></institution-wrap>Boston, 02215 Massachusetts USA </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2167 3675</institution-id><institution-id institution-id-type="GRID">grid.14003.36</institution-id><institution>Department of Biochemistry, National Magnetic Resonance Facility at Madison and BioMagResBank, </institution><institution>University of Wisconsin Madison, </institution></institution-wrap>Madison, 53706 Wisconsin USA </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0378 8294</institution-id><institution-id institution-id-type="GRID">grid.62560.37</institution-id><institution>Cardiovascular Division, Department of Medicine, </institution><institution>Brigham and Women’s Hospital and Harvard Medical School, </institution></institution-wrap>Boston, 02215 Massachusetts USA </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>3</day>
      <month>7</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>3</day>
      <month>7</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <volume>7</volume>
    <elocation-id>210</elocation-id>
    <history>
      <date date-type="received">
        <day>18</day>
        <month>3</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>2</day>
        <month>6</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2020</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">The chemical composition of saccharide complexes underlies their biomedical activities as biomarkers for cardiometabolic disease, various types of cancer, and other conditions. However, because these molecules may undergo major structural modifications, distinguishing between compounds of saccharide and non-saccharide origin becomes a challenging computational problem that hinders the aggregation of information about their bioactive moieties. We have developed an algorithm and software package called “Cheminformatics Tool for Probabilistic Identification of Carbohydrates” (CTPIC) that analyzes the covalent structure of a compound to yield a probabilistic measure for distinguishing saccharides and saccharide-derivatives from non-saccharides. CTPIC analysis of the RCSB Ligand Expo (database of small molecules found to bind proteins in the Protein Data Bank) led to a substantial increase in the number of ligands characterized as saccharides. CTPIC analysis of Protein Data Bank identified 7.7% of the proteins as saccharide-binding. CTPIC is freely available as a webservice at (<ext-link ext-link-type="uri" xlink:href="http://ctpic.nmrfam.wisc.edu">http://ctpic.nmrfam.wisc.edu</ext-link>).</p>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Carbohydrates</kwd>
      <kwd>Software</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000057</institution-id>
            <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>P41GM103399</award-id>
        <award-id>R01GM109046</award-id>
        <award-id>P41GM111135</award-id>
        <award-id>R01GM109046</award-id>
        <award-id>P41GM111135</award-id>
        <award-id>P41GM103399</award-id>
        <award-id>R01GM109046</award-id>
        <award-id>P41GM111135</award-id>
        <award-id>P41GM103399</award-id>
        <award-id>R01GM109046</award-id>
        <principal-award-recipient>
          <name>
            <surname>Dashti</surname>
            <given-names>Hesam</given-names>
          </name>
          <name>
            <surname>Wedell</surname>
            <given-names>Jonathan R.</given-names>
          </name>
          <name>
            <surname>Eghbalnia</surname>
            <given-names>Hamid R.</given-names>
          </name>
          <name>
            <surname>Markley</surname>
            <given-names>John L.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000050</institution-id>
            <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>T32 HL007575</award-id>
        <award-id>R01 HL134811</award-id>
        <award-id>HL 117861</award-id>
        <award-id>K24 HL136852</award-id>
        <award-id>R01 HL134811</award-id>
        <award-id>HL 117861</award-id>
        <award-id>K24 HL136852</award-id>
        <principal-award-recipient>
          <name>
            <surname>Dashti</surname>
            <given-names>Hesam</given-names>
          </name>
          <name>
            <surname>Mora</surname>
            <given-names>Samia</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2020</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1" sec-type="introduction">
    <title>Introduction</title>
    <p id="Par2">Changes in the composition or structure of saccharide compounds can alter their bioactivities<sup><xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR4">4</xref></sup>. Saccharide complexes, including glycans, have been identified as biomarkers of cancer<sup><xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR8">8</xref></sup>, Alzheimer<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>, and other conditions<sup><xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR13">13</xref></sup>. In addition, as we and other groups have shown, saccharide complexes can be used as reliable biomarkers of cardiometabolic diseases and systemic inflammation<sup><xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR18">18</xref></sup>. Global efforts have focused on organizing information about the bioactivities, structures, biosynthesis, and degradation patterns of saccharides and their conjugates in a variety of databases including Protein Data Bank (PDB)<sup><xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR21">21</xref></sup>, RCSB PDB Ligand Expo<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, CCMRD<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, and the KEGG glycan database<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. One example of these efforts is the GlyGen Project (<ext-link ext-link-type="uri" xlink:href="https://www.glygen.org">https://www.glygen.org</ext-link>) funded by the US National Institutes of Health as part of an international effort aimed at developing computational and informatics resources and tools for glycosciences research.</p>
    <p id="Par3">We have previously shown that assigning unique identifiers to chemical compounds is an essential step for aggregating information from different experimental and theoretical metabolomics databases<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>. Before developing such unique identifiers for saccharide complexes, a prerequisite step is to first identify whether a chemical compound has a saccharide origin. Distinguishing saccharide-derivatives from non-saccharide compounds is a challenging computational problem because saccharides complexes may undergo chemical reactions that result in major structural modifications<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p>
    <p id="Par4">We present here an algorithm and software package called “Cheminformatics Tool for Probabilistic Identification of Carbohydrates” (CTPIC) that addresses the essential need for a method for identifying saccharides and their derivatives in a way that distinguishes them from compounds of non-saccharide origin. CTPIC provides two probabilistic scores to report similarities between a given chemical compound and saccharide structures: one score for the probability of the highest scoring fragment of the molecule, and another score for the entire molecule. Molecular fragments of a given compound are analyzed to identify fragments that resemble structures of saccharides. The number of atoms in the identified fragments over the total number of atoms in the compound are considered as the compound probability, which represents the fraction of the compound that is similar to saccharide structures. Among these fragments, the fragment that is most similar to saccharide structures is then used to calculate the fragment probability of the compound.</p>
    <p id="Par5">We demonstrate how this tool can be used to annotate the carbohydrate relatedness of compounds in a ligand structural library and to classify proteins as saccharide-binding on the basis of their structures.</p>
  </sec>
  <sec id="Sec2" sec-type="results">
    <title>Results</title>
    <sec id="Sec3">
      <title>CTPIC: availability and use</title>
      <p id="Par6">The probabilistic algorithm has been developed in Python, and the source codes are publicly available through GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/htdashti/ctpic">https://github.com/htdashti/ctpic</ext-link>). In addition, the method is freely available through a web server (<ext-link ext-link-type="uri" xlink:href="http://ctpic.nmrfam.wisc.edu">http://ctpic.nmrfam.wisc.edu</ext-link>) that accepts as its input the three-dimensional covalent structures of small molecules in SDF or MOL format<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. After executing the probabilistic method in the background, the results are made available through the website. For each queried compound, the output report contains a list of molecular fragments that are found to be similar to known saccharides or their derivatives. The web server uses ALATIS<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup> unique atom identifiers in reporting these fragments. In addition, the web server utilizes the Open Babel<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> package (<ext-link ext-link-type="uri" xlink:href="http://openbabel.org">http://openbabel.org</ext-link>) for identifying ligands in the RCSB PDB Ligand Expo<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> library that are structurally similar to the queried compound. The result page on the website will report the top five most similar ligands and their corresponding protein-ligand complexes on the PDB website<sup><xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR21">21</xref></sup>.</p>
    </sec>
    <sec id="Sec4">
      <title>Validation of the approach for probabilistic identification of saccharide compounds</title>
      <p id="Par7">We show here that our method assigns high probabilities to known saccharides and low probabilities to non-saccharides. For a given structure file of a chemical compound, CTPIC identifies fragments of the compound that can be mapped to saccharide structures. The fragment with the highest probability of being a saccharide-derivative is called the best fragment, and its assigned probability is used to report the similarity score of the compound to saccharide structures. We used CTPIC to assess the probabilities for sets of known saccharide and non-saccharide compounds.</p>
      <sec id="Sec5">
        <title>Analysis of known saccharide and non-saccharide compounds</title>
        <p id="Par8">100 non-saccharide chemical compounds were extracted manually from the Maybridge Ro3 fragment library (<ext-link ext-link-type="uri" xlink:href="https://www.maybridge.com/">https://www.maybridge.com/</ext-link>), and their 3D structures were obtained from the GISSMO website<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR30">30</xref></sup>. CTPIC assigned probabilities of zero to each of these compounds. Two examples of these compounds are shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>; results from the entire set of non-saccharide examples are on (<ext-link ext-link-type="uri" xlink:href="http://ctpic.nmrfam.wisc.edu">http://ctpic.nmrfam.wisc.edu</ext-link>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Examples of compounds analyzed by CTPIC. Non-saccharide compounds yielding scores of 0: (<bold>a</bold>) isonicotinic acid [C<sub>6</sub>H<sub>5</sub>NO<sub>2</sub>] and (<bold>b</bold>) 1-benzothiophen-5-amine [C<sub>8</sub>H<sub>7</sub>NS]. Saccharide compounds yielding scores of 1.0: (<bold>c</bold>) fucose [C<sub>6</sub>H<sub>12</sub>O<sub>5</sub>] and (<bold>d</bold>) N-acetylglucosamine [C<sub>8</sub>H<sub>15</sub>N<sub>1</sub>O<sub>6</sub>].</p></caption><graphic xlink:href="41597_2020_547_Fig1_HTML" id="d30e581"/></fig></p>
        <p id="Par9">We selected 100 saccharide derivatives, including aldoses, ketoses, amino sugars, and intramolecular anhydrides, from an IUPAC publication on carbohydrate nomenclature<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. CTPIC assigned high probabilities to these compounds (mean: 0.98, STD: 0.04). Two examples of these compounds are shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>; result from the entire set is available on the website.</p>
        <p id="Par10">These examples of non-saccharide and saccharide compounds show that the calculated probabilities can be used as an indicator of the similarity between given small molecules and saccharide structures. Therefore, the algorithm can be used as a binary classifier (saccharide vs. non-saccharide). On these examined sets of 100 saccharides and 100 non-saccharides, the accuracy of CTPIC, as a binary classifier, was 100%.</p>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Application of the approach to identifying saccharides in structural databases</title>
      <sec id="Sec7">
        <title>Identification of compounds in the RCSB PDB Ligand Expo database that contain saccharide fragments</title>
        <p id="Par11">The RCSB PDB Ligand Expo<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> is a database that contains three-dimensional structures of 29,993 small molecules (structure files downloaded on October 1, 2019) that have been found to be associated with structures of biological macromolecules deposited in the Protein Data Bank (PDB). 28,988 of these entries have been assigned to a “Component type” (Table <xref rid="Tab1" ref-type="table">1</xref>). As indicated in the table, a total of 571 entries were annotated as “saccharide” (marked with asterisks: saccharide; D-saccharide; D-saccharide 1,4 and 1,4 linking; L-saccharide; L-saccharide 1,4 and 1,4 linking). We utilized CTPIC to analyze each of the 29,993 compounds in the RCSB PDB Ligand Expo database to determine their saccharide fragment and compound probability scores. These are shown as a scatter plot in Fig. <xref rid="Fig2" ref-type="fig">2</xref>. The complete list of the entries and their assigned probabilities are available on the website (<ext-link ext-link-type="uri" xlink:href="http://ctpic.nmrfam.wisc.edu">http://ctpic.nmrfam.wisc.edu</ext-link>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Annotated components types archived in the RCSB PDB Ligand Expo.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Component Type</th><th># entries</th><th>Component Type</th><th># entries</th></tr></thead><tbody><tr><td>non-polymer</td><td>26566</td><td>L-peptide linking</td><td>1182</td></tr><tr><td>* saccharide</td><td>200</td><td>D-peptide linking</td><td>123</td></tr><tr><td>* D-saccharide</td><td>299</td><td>peptide-like</td><td>539</td></tr><tr><td>* D-saccharide 1,4 and 1,4 linking</td><td>13</td><td>peptide linking</td><td>77</td></tr><tr><td>* L-saccharide</td><td>58</td><td>D-beta-peptide, C-gamma linking</td><td>1</td></tr><tr><td>* L-saccharide 1,4 and 1,4 linking</td><td>1</td><td>D-gamma-peptide, C-delta linking</td><td>1</td></tr><tr><td>RNA linking</td><td>287</td><td>L-gamma-peptide, C-delta linking</td><td>1</td></tr><tr><td>L-RNA linking</td><td>5</td><td>L-peptide COOH carboxy terminus</td><td>9</td></tr><tr><td>L-DNA linking</td><td>4</td><td>D-peptide NH3 amino terminus</td><td>2</td></tr><tr><td>DNA linking</td><td>405</td><td>L-beta-peptide, C-gamma linking</td><td>1</td></tr><tr><td>DNA OH 3 prime terminus</td><td>3</td><td>RNA OH 5 prime terminus</td><td>1</td></tr><tr><td>DNA OH 5 prime terminus</td><td>2</td><td>RNA OH 3 prime terminus</td><td>2</td></tr><tr><td>L-peptide NH3 amino terminus</td><td>13</td><td>NA</td><td>198</td></tr></tbody></table></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>Scatter plot of calculated probabilities for the RCSB PDB Ligand Expo entries. The <italic>y</italic>-axis indicates the best fragment probability, and the <italic>x</italic>-axis shows the compound probability. In this plot, the 571 compounds that were annotated in this database as “saccharide” are shown as filled black diamonds, and the remaining compounds are shown as grey circles.</p></caption><graphic xlink:href="41597_2020_547_Fig2_HTML" id="d30e827"/></fig></p>
        <p id="Par12">CTPIC assigned fragment and compound probabilities of “zero” to five of the entries annotated as “saccharide”. One of these entries, entry ID <italic>GTE</italic> with the chemical formula “OH”, was mistakenly annotated as a saccharide. The remaining four entries, shown in Fig. <xref rid="Fig3" ref-type="fig">3a–d</xref>, represent compounds that the probabilistic method failed to identify as saccharide derivatives owing to their lack of sufficient diagnostic oxygen atoms. Apart from these five entries, the lowest fragment probability of the 571 entries annotated as “saccharide” was 0.97. The two entries with probability of 0.97 are shown in Fig. <xref rid="Fig3" ref-type="fig">3e,f</xref>; their lower than 1.0 score can be attributed to the structural modifications of their saccharide moieties.<fig id="Fig3"><label>Fig. 3</label><caption><p>Examples of the saccharide compounds in RCSB PDB Ligand Expo database. (<bold>a–d</bold>) These compounds were assigned probabilities of “zero” due to the lack of sufficient oxygen atoms: (<bold>a</bold>) 2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl, entry ID: <italic>ADR</italic>, formula: C<sub>6</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>, (<bold>b</bold>) [O4]-acetoxy-2,3-dideoxyfucose, entry ID: <italic>ARI</italic>, formula: C<sub>8</sub>H<sub>14</sub>O<sub>4</sub>, (<bold>c</bold>) 2,3-dideoxyfucose, entry ID: <italic>CDR</italic>, formula: C<sub>6</sub>H<sub>12</sub>O<sub>3</sub>, (<bold>d</bold>) 3,4-dideoxy-2,6-amino-α-D galactopyranose, entry ID: <italic>GE1</italic>, formula: C<sub>6</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>. <bold>(e,f)</bold> Compounds with fragment probabilities of 0.97: (<bold>e</bold>) D-arabinohydroxamic acid, entry ID: <italic>HDL</italic>, formula: C<sub>5</sub>H<sub>9</sub>NO<sub>7</sub>, compound probability: 0.92, (f) D-fructuronic acid, entry ID: <italic>FIX</italic>, formula: C<sub>6</sub>H<sub>8</sub>O<sub>7</sub>, compound probability: 1.00. <bold>(g,h)</bold> Compounds with the lowest compound probabilities: (<bold>g</bold>) n-[(1 s,2r,3 s)-1-[(α-D-galactopyranosyloxy) methyl]-2,3-dihydroxy heptadecyl] hexacosanamide, entry ID: <italic>AGH</italic>, formula: C<sub>50</sub>H<sub>99</sub>NO<sub>9</sub>, compound probability: 0.35, (h) (2 R,3 R,4 S,5 S)-4-fluoro-3,5-dihydroxytetra hydrofuran-2-yl 2-phenylethyl hydrogen S-phosphate, entry ID: 46Z, formula: C<sub>12</sub>H<sub>16</sub>FO<sub>7</sub>P, compound probability: 0.38.</p></caption><graphic xlink:href="41597_2020_547_Fig3_HTML" id="d30e980"/></fig></p>
        <p id="Par13">Several entries annotated as “saccharide” received fragment probability of “1” but low compound probabilities. These entries contain a saccharide fragment modified by atoms that do not constitute a saccharide structure. The compounds with the lowest compound probabilities (0.35 and 0.38) corresponded to entry ID <italic>AGH</italic> and ID <italic>46Z</italic>, respectively. As shown in Fig. <xref rid="Fig3" ref-type="fig">3g,h</xref>, both of these entries contain a saccharide fragment; however, the long methylene chains in entry ID <italic>AGH</italic> and the phenyl ring in entry ID <italic>46Z</italic> resulted in the low compound probabilities.</p>
        <p id="Par14">Examination of these structures led us to choose fragment scores of 0.97 and higher, and compound scores of 0.35 and higher as the thresholds for designating a compound as having “saccharide” origin. According to this designation, the RCSB PDB Ligand Expo contains 4,553 compounds scored as “saccharide”, which is 3,982 more than the original number of 571. The entire set of compounds newly annotated as “saccharide” is available on the website. Compounds that exemplify the extremes of this classification range are shown in Fig. <xref rid="Fig4" ref-type="fig">4</xref>. Mycalolide B (entry ID <italic>JQV</italic>, Fig. <xref rid="Fig4" ref-type="fig">4a</xref>) received the lowest scores for “saccharide” designation. It contains a saccharide fragment (highlighted in green) plus extensive non-saccharide moieties. At the other end of the scale, β-D-fructofuranosyl-(2- &gt; 6)-beta-D-fructofuranosyl-(2- &gt; 6)-beta-D-fructofuranose (entry ID <italic>0UB</italic>, Fig. <xref rid="Fig4" ref-type="fig">4b</xref>) received fragment and compound probabilities of 1.0.<fig id="Fig4"><label>Fig. 4</label><caption><p>Two examples of entries from the RCSB PDB Ligand Expo that the probabilistic method suggests to annotate as saccharide-derivatives. (<bold>a</bold>) Mycalolide B, entry ID: <italic>JQV</italic>, formula: C<sub>52</sub>H<sub>76</sub>N<sub>4</sub>O<sub>17</sub>S, fragment probability: 0.97, compound probability: 0.35. A carbohydrate chain is indicated with green lines. (<bold>b</bold>) β-D-fructofuranosyl-(2-&gt;6)-beta-D-fructofuranosyl-(2-&gt;6)-beta-D-fructofuranose, entry ID: <italic>0UB</italic>, formula: C<sub>18</sub>H<sub>32</sub>O<sub>16</sub> fragment and compound probabilities are equal to one.</p></caption><graphic xlink:href="41597_2020_547_Fig4_HTML" id="d30e1058"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Identifying saccharide binding proteins</title>
      <p id="Par15">Lectins and saccharide binding proteins are involved in many biological processes, including cell recognition, cell-cell adhesion, and immune functions<sup><xref ref-type="bibr" rid="CR31">31</xref>–<xref ref-type="bibr" rid="CR35">35</xref></sup>. In this section, we show another application of CTPIC for identification of these macromolecules by probabilistic annotation of small molecule with saccharide origin that bind to the proteins. To show how the method can be used for identifying saccharide binding proteins, we analyzed the cross references from the RCSB Ligand Expo to the PDB structural database of macromolecule complexes<sup><xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR21">21</xref></sup>. The majority of the small molecule structures stored in the Ligand Expo database are extracted from molecular complexes archived in the PDB, and the Ligand Expo database provides cross links between the small molecules and their corresponding macromolecule entries. Analyzing these cross references from the small molecules that are annotated by CTPIC as saccharides to the macromolecules provides a systematic path for identifying saccharide binding proteins in PDB. For example, the small molecule mycalolide B (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>) is linked to the structure of rabbit actin protein (RCSB PDB entry ID <italic>6MGO</italic>, 10.2210/pdb6MGO/pdb). As indicated in the structure of the complex, the carbohydrate region highlighted in (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>) binds to an active site of the protein at threonine-353 and methionine-357. We note that the research article of the RCSB PDB entry ID <italic>6MGO</italic>, with the structural resolution of 2.2 Å, has not been published yet, and therefore identifying this protein as a saccharide-binding protein was not possible through other means. RCSB PDB entry ID <italic>0UB</italic> (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>) is linked to the RCSB PDB macromolecule entry ID <italic>4FFI</italic> (10.2210/pdb4FFI/pdb), which is reported in its associated research article as a saccharide binding proteins in plants<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>.</p>
      <p id="Par16">Because the probabilistic method can identify small molecules as saccharide-derivatives, the macromolecules that bind to these saccharides can be annotated as saccharide binding proteins or lectins. From the 4,553 annotated saccharides and saccharide-derivatives from the Ligand Expo database, 4,409 compounds were cross referenced to 12,297 unique RCSB PDB macromolecules (7.7% of the 158,998 entries archived in the database). The list of these saccharide-binding proteins is available on the website (<ext-link ext-link-type="uri" xlink:href="http://ctpic.nmrfam.wisc.edu">http://ctpic.nmrfam.wisc.edu</ext-link>).</p>
    </sec>
  </sec>
  <sec id="Sec9" sec-type="discussion">
    <title>Discussion</title>
    <p id="Par17">Because of the wide range of bioactivities of saccharides, compounds containing these moieties are at the center of numerous biochemical and biomedical investigations. Saccharide-containing molecules have been identified as biomarkers of disease and pathophysiological irregularities. Recent efforts from the glycomics community highlight the need for aggregating and compiling available metadata about these chemical compounds from across databases. We have introduced here a probabilistic method (CTPIC) for distinguishing compounds that contain saccharide moieties from those that do not. We have demonstrated the abillity of the probabilistic method to distinguish saccharides from non-saccharides and, more importantly, to identify saccharide fragments in chemical compounds that contain both saccharide-like and non-saccharide fragments. We have shown that CTPIC can be used to identify saccharide binding proteins on the basis of analysis of their binding ligands. This probabilistic method addresses an essential need for identifying saccharide complexes, and provides a platform for the design and development of unique identifiers for saccharides complexes and glycans.</p>
  </sec>
  <sec id="Sec10">
    <title>Methods</title>
    <p id="Par18">The probabilistic software program (CTPIC) loads a three-dimensional structure file (in SDF or MOL format<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>) of the compound to be analyzed and uses the NetworkX library<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> to convert the input structure file to a graph data structure, in which atoms are represented as nodes and edges of the graph represent covalent bonds between the atoms. The method looks for ring and chain molecular fragments in the given chemical compound and searches these fragments to identify substructures that we call “saccharide fingerprints”. We defined 37 molecular substructures, or saccharide fingerprints, that were extracted from an IUPAC carbohydrate nomenclature system<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. Two examples of these saccharide fingerprints are shown in Fig. <xref rid="Fig5" ref-type="fig">5a,b</xref>; the complete list of the fingerprints used in the program is available on the website (<ext-link ext-link-type="uri" xlink:href="http://ctpic.nmrfam.wisc.edu">http://ctpic.nmrfam.wisc.edu</ext-link>). Chain or ring molecular fragments that contain saccharide fingerprints are then called “saccharide templates”. Figure <xref rid="Fig5" ref-type="fig">5c</xref> shows an example of such templates: the 5- or 6-membered template ring is attached to three saccharide fingerprints (-OR, -CH<sub>2</sub>OR, -CHROR) with variable R-groups. The R-groups of the saccharide templates allow different atom compositions.<fig id="Fig5"><label>Fig. 5</label><caption><p>Examples of “saccharide fingerprints”. (<bold>a</bold>) Saccharide fingerprint for ring fragments. (<bold>b</bold>) Saccharide fingerprint for chain fragments. (<bold>c</bold>) Larger saccharide template. The dashed line bond between C3 and C4 in the ring indicates that the template can represent 5 or 6 membered rings. R8 can be a hydrogen or any other atom composite (e.g., CH<sub>2</sub>-, CH<sub>3</sub>). R11 and R15 can be any single or composite substructure. For R14 as a hydrogen, C9 and C12 would represent similar fingerprints, however, R14 can also be any heavy atom (e.g., O, OH, NH<sub>3</sub>).</p></caption><graphic xlink:href="41597_2020_547_Fig5_HTML" id="d30e1186"/></fig></p>
    <p id="Par19">For a given compound, CTPIC calculates two probabilities: one that represents the fraction of the compound that can be mapped to saccharide templates (compound probability), and the other that represents the fractional similarity of molecular fragment of the compound with the most similar saccharide template (fragment probability). Figure <xref rid="Fig6" ref-type="fig">6</xref> shows the overall workflow of the probabilistic method on the website. In this process, every chain or ring fragment of a given compound that contains one or more saccharide fingerprints is analyzed for its fragment probability. The fragments that do not contain any saccharide fingerprint serve to reduce the compound probability.<fig id="Fig6"><label>Fig. 6</label><caption><p>Workflow of the web server. For a given small molecule, the web server queries ALATIS to retrieve unique atom labels of the compound. The preprocessing module converts the structure file to a graph data structure, and extracts chain and ring molecular fragments. Then every fragment is analyzed to identify saccharide fingerprints. If no fingerprint found, the fragment is used in calculating a <italic>compound penalty</italic>. The molecular fragments that contain saccharide fingerprints are used in calculating the <italic>minimum fragment penalty</italic>. This penalty and the compound penalty are then used in calculating the probabilities. The web server reports the calculated probabilities and also lists every other calculated <italic>fragment penalty</italic> for the molecular fragments. In parallel, the web server uses the Open Babel package for identifying ligands with the highest structural similarities to the submitted molecule. These ligands from the RCSB PDB Ligand Expo are cross-referenced to the PDB molecular complexes. The outcome of this structural analysis reports proteins from PDB that bind to the identified ligands.</p></caption><graphic xlink:href="41597_2020_547_Fig6_HTML" id="d30e1209"/></fig></p>
    <p id="Par20">After identifying saccharide fingerprints in a fragment and mapping the fragment to a saccharide template, the deviations of the fragment’s chemical formula from the aldehydes or ketones formula (C<sub>n</sub>[HOH]<sub>m</sub>) constitute fragment penalties. For example, (E)-2,5-dihydroxyhex-3-enedioic acid (Fig. <xref rid="Fig7" ref-type="fig">7a</xref>,formula: C<sub>6</sub>H<sub>8</sub>O<sub>6</sub>, PubChem CID: 88515755) is a chain compound, symmetric around a double bond and contains two carboxylic acids and two CHOH groups. These groups are saccharide fingerprints as defined in CTPIC, and, as such, the entire compound is considered as one molecular fragment mapped onto one saccharide template. The double bond is considered as a structural modification that resulted from the removal of two OH groups and counts as a penalty for the molecular fragment. In this example, the entire compound was mapped to one saccharide template; therefore, because there is no residual structure to be considered, the compound penalty is 0. These two types of penalties and the way they are used to calculate CTPIC probabilities are explained below.<fig id="Fig7"><label>Fig. 7</label><caption><p>Structures of compounds used to illustrate the CTPIC algorithm. (<bold>a</bold>) (E)-2,5-Dihydroxyhex-3-enedioic acid, PubChem CID: 88515755, (<bold>b</bold>) 1,3-Diaminopropane, PubChem CID: 428.</p></caption><graphic xlink:href="41597_2020_547_Fig7_HTML" id="d30e1245"/></fig></p>
    <sec id="Sec11">
      <title>Calculating fragment penalty</title>
      <p id="Par21">When a ring or chain molecular fragment contains one or more saccharide fingerprints, the ratio of the number of required atom substitutions over the total number of atoms in the fragment is used as a penalty value. In this way, molecular fragments are assigned a penalty value that represents the lowest number of atom substitutions required to convert the fragment to a saccharide template. Of all molecular fragments that have been mapped to saccharide templates, the one with the minimum penalty is characterized by the <italic>minimum fragment penalty</italic>, i.e., a number between 0 and 1.</p>
    </sec>
    <sec id="Sec12">
      <title>Calculating compound penalty</title>
      <p id="Par22">The portion of an input molecule that cannot be mapped onto a saccharide template is used in calculating the “<italic>compound penalty</italic>”. The compound penalty indicates the ratio of the number of atoms in the input compound that could not be mapped to a saccharide template over the total number of atoms in the molecule. For example, 1,3-diaminopropane (Fig. <xref rid="Fig7" ref-type="fig">7b</xref>, chemical formula: C<sub>3</sub>H<sub>10</sub>N<sub>2</sub>, PubChem CID: 428) cannot be mapped to any saccharide fingerprint; and, therefore, the number of atoms that cannot be mapped to saccharide templates over the total number of atoms in the compound equals to 1, which is the compound penalty of this compound.</p>
      <p id="Par23">Because the <italic>minimum fragment penalty</italic> and the <italic>compound penalty</italic> are values between 0 and 1, we calculate the fragment and compound probabilities as one minus the penalties. Therefore, the fragment probability indicates the highest probability that a molecular fragment in the compound can be a saccharide-derivative, and the compound probability indicates the portion of the compound that can be mapped to saccharide templates.</p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>This study made use of the National Magnetic Resonance Facility at Madison, which is supported by National Institutes of Health (NIH) grant P41GM103399 and the BioMagResBank, which is supported by NIH grant R01GM109046. H.D., J.R.W., and H.R.E. were supported in part by the National Center for Biomolecular NMR Data Processing and Analysis, which is supported by NIH grant P41GM111135 (NIGMS). H.D. and S.M. were supported in part by National Heart Lung and Blood Institute (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases T32 HL007575, R01 HL134811, HL 117861, and K24 HL136852. O.V.D. is supported in part by NHLBI 5K01HL135342. Marvin (Marvin 16.7.11, 2016, ChemAxon <ext-link ext-link-type="uri" xlink:href="http://www.chemaxon.com">http://www.chemaxon.com</ext-link>) was used primarily for drawing, displaying, and characterizing chemical structures, except as otherwise indicated.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>H.D., W.M.W., H.R.E., J.L.M. and S.M. contributed in conceptualization and planning stages. H.D., W.M.W. and O.V.D. designed the algorithm. H.D. and J.R.W. developed the web server. H.D., J.L.M. and S.M. prepared the manuscript. W.M.W., H.R.E. and J.L.M. provided expertise in chemistry, both during the planning stage, and during the software implementation. All authors provided feedback, were involved in editing the initial draft, and reviewed the manuscript.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Data availability</title>
    <p>The output results on the RCSB PDB Ligand Expo are available on our website, and also have been deposited to the public domain through Open Science Framework [10.17605/OSF.IO/Y4U8M]<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. The entries that were annotated as saccharides using the probabilistic method and their cross-references to the RCSB PDB macromolecule entries are also available on both our website and the Open Science Framework page<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Code availability</title>
    <p>The cheminformatic tool for probabilistic identification of carbohydrate (CTPIC) program was developed using Python and is available on our website (<ext-link ext-link-type="uri" xlink:href="http://ctpic.nmrfam.wisc.edu">http://ctpic.nmrfam.wisc.edu</ext-link>) as a web server. In addition, the source codes are available through GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/htdashti/ctpic">https://github.com/htdashti/ctpic</ext-link>).</p>
  </notes>
  <notes id="FPar1" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par24">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Reis</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Osorio</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Silva</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Gomes</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>David</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Alterations in glycosylation as biomarkers for cancer detection</article-title>
        <source>Journal of Clinical Pathology</source>
        <year>2010</year>
        <volume>63</volume>
        <fpage>322</fpage>
        <lpage>329</lpage>
        <pub-id pub-id-type="doi">10.1136/jcp.2009.071035</pub-id>
        <?supplied-pmid 20354203?>
        <pub-id pub-id-type="pmid">20354203</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kang</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Elbein</surname>
            <given-names>AD</given-names>
          </name>
        </person-group>
        <article-title>Alterations in the structure of the oligosaccharide of vesicular stomatitis virus G protein by swainsonine</article-title>
        <source>Journal of Virology</source>
        <year>1983</year>
        <volume>46</volume>
        <fpage>60</fpage>
        <lpage>69</lpage>
        <pub-id pub-id-type="doi">10.1128/JVI.46.1.60-69.1983</pub-id>
        <pub-id pub-id-type="pmid">6298470</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Freeze</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Koza-Taylor</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Saunders</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cardelli</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>The effects of altered N-linked oligosaccharide structures on maturation and targeting of lysosomal enzymes in Dictyostelium discoideum</article-title>
        <source>Journal of Biological Chemistry</source>
        <year>1989</year>
        <volume>264</volume>
        <fpage>19278</fpage>
        <lpage>19286</lpage>
        <?supplied-pmid 2509475?>
        <pub-id pub-id-type="pmid">2509475</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moriwaki</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Alteration of N-linked oligosaccharide structures of human chorionic gonadotropin beta-subunit by disruption of disulfide bonds</article-title>
        <source>Glycoconjugate Journal</source>
        <year>1997</year>
        <volume>14</volume>
        <fpage>225</fpage>
        <lpage>229</lpage>
        <pub-id pub-id-type="doi">10.1023/a:1018593805890</pub-id>
        <?supplied-pmid 9111139?>
        <pub-id pub-id-type="pmid">9111139</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kirmiz</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A serum glycomics approach to breast cancer biomarkers</article-title>
        <source>Molecular and Cellular Proteomics</source>
        <year>2007</year>
        <volume>6</volume>
        <fpage>43</fpage>
        <lpage>55</lpage>
        <pub-id pub-id-type="doi">10.1074/mcp.M600171-MCP200</pub-id>
        <?supplied-pmid 16847285?>
        <pub-id pub-id-type="pmid">16847285</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kailemia</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lebrilla</surname>
            <given-names>CB</given-names>
          </name>
        </person-group>
        <article-title>Glycans and glycoproteins as specific biomarkers for cancer</article-title>
        <source>Anal Bioanal Chem</source>
        <year>2017</year>
        <volume>409</volume>
        <fpage>395</fpage>
        <lpage>410</lpage>
        <pub-id pub-id-type="doi">10.1007/s00216-016-9880-6</pub-id>
        <?supplied-pmid 27590322?>
        <pub-id pub-id-type="pmid">27590322</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Adamczyk</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Tharmalingam</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Rudd</surname>
            <given-names>PM</given-names>
          </name>
        </person-group>
        <article-title>Glycans as cancer biomarkers</article-title>
        <source>Biochimica et Biophysica Acta</source>
        <year>2012</year>
        <volume>1820</volume>
        <fpage>1347</fpage>
        <lpage>1353</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbagen.2011.12.001</pub-id>
        <?supplied-pmid 22178561?>
        <pub-id pub-id-type="pmid">22178561</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yin</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Lloyd</surname>
            <given-names>KO</given-names>
          </name>
        </person-group>
        <article-title>Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16</article-title>
        <source>Journal of Biological Chemistry</source>
        <year>2001</year>
        <volume>276</volume>
        <fpage>27371</fpage>
        <lpage>27375</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M103554200</pub-id>
        <?supplied-pmid 11369781?>
        <pub-id pub-id-type="pmid">11369781</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <mixed-citation publication-type="other">Regan, P., McClean, P. L., Smyth, T. &amp; Doherty, M. Early Stage Glycosylation Biomarkers in Alzheimer’s Disease. <italic>Medicines</italic><bold>6</bold>, 10.3390/medicines6030092 (2019).</mixed-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kizuka</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kitazume</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Taniguchi</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>N-glycan and Alzheimer’s disease</article-title>
        <source>Biochimica et Biophysica Acta</source>
        <year>2017</year>
        <volume>1861</volume>
        <fpage>2447</fpage>
        <lpage>2454</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbagen.2017.04.012</pub-id>
        <?supplied-pmid 28465241?>
        <pub-id pub-id-type="pmid">28465241</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gudelj</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Lauc</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Pezer</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Immunoglobulin G glycosylation in aging and diseases</article-title>
        <source>Cell Immunology</source>
        <year>2018</year>
        <volume>333</volume>
        <fpage>65</fpage>
        <lpage>79</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cellimm.2018.07.009</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dias</surname>
            <given-names>AM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Glycans as critical regulators of gut immunity in homeostasis and disease</article-title>
        <source>Cellular Immunology</source>
        <year>2018</year>
        <volume>333</volume>
        <fpage>9</fpage>
        <lpage>18</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cellimm.2018.07.007</pub-id>
        <?supplied-pmid 30049413?>
        <pub-id pub-id-type="pmid">30049413</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Akasaka-Manya</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Excess APP O-glycosylation by GalNAc-T6 decreases Abeta production</article-title>
        <source>Journal of Biochemistry</source>
        <year>2017</year>
        <volume>161</volume>
        <fpage>99</fpage>
        <lpage>111</lpage>
        <pub-id pub-id-type="doi">10.1093/jb/mvw056</pub-id>
        <?supplied-pmid 28053144?>
        <pub-id pub-id-type="pmid">28053144</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dierckx</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Verstockt</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Vermeire</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>van Weyenbergh</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD</article-title>
        <source>Journal of Crohn’s and Colitis</source>
        <year>2019</year>
        <volume>13</volume>
        <fpage>389</fpage>
        <lpage>394</lpage>
        <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjy162</pub-id>
        <?supplied-pmid 30312386?>
        <pub-id pub-id-type="pmid">30312386</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Akinkuolie</surname>
            <given-names>AO</given-names>
          </name>
          <name>
            <surname>Buring</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Ridker</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Mora</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>A novel protein glycan biomarker and future cardiovascular disease events</article-title>
        <source>J Am Heart Assoc</source>
        <year>2014</year>
        <volume>3</volume>
        <fpage>e001221</fpage>
        <pub-id pub-id-type="doi">10.1161/JAHA.114.001221</pub-id>
        <?supplied-pmid 25249300?>
        <pub-id pub-id-type="pmid">25249300</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lawler</surname>
            <given-names>PR</given-names>
          </name>
        </person-group>
        <article-title>Glycomics and Cardiovascular Disease: Advancing Down the Path Towards Precision</article-title>
        <source>Circulation Research</source>
        <year>2018</year>
        <volume>122</volume>
        <fpage>1488</fpage>
        <lpage>1490</lpage>
        <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.313054</pub-id>
        <?supplied-pmid 29798896?>
        <pub-id pub-id-type="pmid">29798896</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McGarrah</surname>
            <given-names>RW</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality</article-title>
        <source>Clinical Chemistry</source>
        <year>2017</year>
        <volume>63</volume>
        <fpage>288</fpage>
        <lpage>296</lpage>
        <pub-id pub-id-type="doi">10.1373/clinchem.2016.261636</pub-id>
        <?supplied-pmid 27811210?>
        <pub-id pub-id-type="pmid">27811210</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <mixed-citation publication-type="other">Connelly, M. A., Otvos, J. D., Shalaurova, I., Playford, M. P. &amp; Mehta, N. N. GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. <italic>Journal of Translational Medicine</italic><bold>15</bold>, 10.1186/s12967-017-1321-6 (2017).</mixed-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Henrick</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Markley</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data</article-title>
        <source>Nucleic Acids Res</source>
        <year>2007</year>
        <volume>35</volume>
        <fpage>D301</fpage>
        <lpage>303</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkl971</pub-id>
        <?supplied-pmid 17142228?>
        <pub-id pub-id-type="pmid">17142228</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Henrick</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Announcing the worldwide Protein Data Bank</article-title>
        <source>Nature Structral Biology</source>
        <year>2003</year>
        <volume>10</volume>
        <fpage>980</fpage>
        <pub-id pub-id-type="doi">10.1038/nsb1203-980</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>ww</surname>
            <given-names>PDBC</given-names>
          </name>
        </person-group>
        <article-title>Protein Data Bank: the single global archive for 3D macromolecular structure data</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>D520</fpage>
        <lpage>D528</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky949</pub-id>
        <pub-id pub-id-type="pmid">30357364</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Feng</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ligand Depot: a data warehouse for ligands bound to macromolecules</article-title>
        <source>Bioinformatics</source>
        <year>2004</year>
        <volume>20</volume>
        <fpage>2153</fpage>
        <lpage>2155</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bth214</pub-id>
        <?supplied-pmid 15059838?>
        <pub-id pub-id-type="pmid">15059838</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <mixed-citation publication-type="other">Kang, X. <italic>et al</italic>. CCMRD: a solid-state NMR database for complex carbohydrates. <italic>Journal of Biomolecular NMR</italic>, 10.1007/s10858-020-00304-2 (2020).</mixed-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hashimoto</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>KEGG as a glycome informatics resource</article-title>
        <source>Glycobiology</source>
        <year>2006</year>
        <volume>16</volume>
        <fpage>63R</fpage>
        <lpage>70R</lpage>
        <pub-id pub-id-type="doi">10.1093/glycob/cwj010</pub-id>
        <?supplied-pmid 16014746?>
        <pub-id pub-id-type="pmid">16014746</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dashti</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Westler</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Markley</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Eghbalnia</surname>
            <given-names>HR</given-names>
          </name>
        </person-group>
        <article-title>Unique identifiers for small molecules enable rigorous labeling of their atoms</article-title>
        <source>Scientific Data</source>
        <year>2017</year>
        <volume>4</volume>
        <fpage>170073</fpage>
        <pub-id pub-id-type="doi">10.1038/sdata.2017.73</pub-id>
        <?supplied-pmid 28534867?>
        <pub-id pub-id-type="pmid">28534867</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dashti</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wedell</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Westler</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Markley</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Eghbalnia</surname>
            <given-names>HR</given-names>
          </name>
        </person-group>
        <article-title>Automated evaluation of consistency within the PubChem Compound database</article-title>
        <source>Scientific Data</source>
        <year>2019</year>
        <volume>6</volume>
        <fpage>190023</fpage>
        <pub-id pub-id-type="doi">10.1038/sdata.2019.23</pub-id>
        <?supplied-pmid 30778259?>
        <pub-id pub-id-type="pmid">30778259</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McNaught</surname>
            <given-names>AD</given-names>
          </name>
        </person-group>
        <article-title>Nomenclature of carbohydrates</article-title>
        <source>Carbohydrate Research</source>
        <year>1997</year>
        <volume>297</volume>
        <fpage>1</fpage>
        <lpage>92</lpage>
        <pub-id pub-id-type="doi">10.1016/s0008-6215(97)83449-0</pub-id>
        <?supplied-pmid 9042704?>
        <pub-id pub-id-type="pmid">9042704</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dalby</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Description of several chemical structure file formats used by computer programs developed at Molecular Design Limited</article-title>
        <source>Journal of Chemical Information and Modeling</source>
        <year>1992</year>
        <volume>32</volume>
        <fpage>244</fpage>
        <lpage>255</lpage>
        <pub-id pub-id-type="doi">10.1021/ci00007a012</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>O’Boyle</surname>
            <given-names>NM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Open Babel: An open chemical toolbox</article-title>
        <source>Journal of Cheminformatics</source>
        <year>2011</year>
        <volume>3</volume>
        <fpage>33</fpage>
        <pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>
        <?supplied-pmid 21982300?>
        <pub-id pub-id-type="pmid">21982300</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dashti</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Applications of Parametrized NMR Spin Systems of Small Molecules</article-title>
        <source>Analytical Chemistry</source>
        <year>2018</year>
        <volume>90</volume>
        <fpage>10646</fpage>
        <lpage>10649</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.analchem.8b02660</pub-id>
        <?supplied-pmid 30125102?>
        <pub-id pub-id-type="pmid">30125102</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nangia-Makker</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Conklin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hogan</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Raz</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents</article-title>
        <source>Trends in Molecular Medicine</source>
        <year>2002</year>
        <volume>8</volume>
        <fpage>187</fpage>
        <lpage>192</lpage>
        <pub-id pub-id-type="doi">10.1016/s1471-4914(02)02295-5</pub-id>
        <?supplied-pmid 11927277?>
        <pub-id pub-id-type="pmid">11927277</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>De Mejia</surname>
            <given-names>EG</given-names>
          </name>
          <name>
            <surname>Prisecaru</surname>
            <given-names>VI</given-names>
          </name>
        </person-group>
        <article-title>Lectins as bioactive plant proteins: a potential in cancer treatment</article-title>
        <source>Critical Reviews in Food Science and Nutrition</source>
        <year>2005</year>
        <volume>45</volume>
        <fpage>425</fpage>
        <lpage>445</lpage>
        <pub-id pub-id-type="doi">10.1080/10408390591034445</pub-id>
        <?supplied-pmid 16183566?>
        <pub-id pub-id-type="pmid">16183566</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <mixed-citation publication-type="other">Collins, B. E., Yang, L. J. S. &amp; Schnaar, R. L. In <italic>Sphingolipid Metabolism and Cell Signaling, Part B</italic> Vol. 312 <italic>Methods in Enzymology</italic> (eds Alfred H. Merrill &amp; Yusuf A. Hannun) 438–446 (Academic Press, 2000).</mixed-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <mixed-citation publication-type="other">Cammarata, M., Parisi, M. G. &amp; Vasta, G. R. In <italic>Lessons in</italic><italic>Immunity</italic> (eds Loriano Ballarin &amp; Matteo Cammarata) 239–256 (Academic Press, 2016).</mixed-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Copoiu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Torres</surname>
            <given-names>PHM</given-names>
          </name>
          <name>
            <surname>Ascher</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Blundell</surname>
            <given-names>TL</given-names>
          </name>
          <name>
            <surname>Malhotra</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>ProCarbDB: a database of carbohydrate-binding proteins</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <fpage>D368</fpage>
        <lpage>D375</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz860</pub-id>
        <?supplied-pmid 31598690?>
        <pub-id pub-id-type="pmid">31598690</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Park</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Structural and functional basis for substrate specificity and catalysis of levan fructotransferase</article-title>
        <source>Journal of Biological Chemistry</source>
        <year>2012</year>
        <volume>287</volume>
        <fpage>31233</fpage>
        <lpage>31241</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M112.389270</pub-id>
        <?supplied-pmid 22810228?>
        <pub-id pub-id-type="pmid">22810228</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <mixed-citation publication-type="other">Hagberg, A. A., Schult, D. A. &amp; Swart, P. J. In <italic>Proceedings of the 7th Python in Science conference (SciPy 2008)</italic>. (ed T Vaught G Varoquaux, J Millman).</mixed-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <mixed-citation publication-type="other">McNaught, A. D. In <italic>Advances in Carbohydrate Chemistry and Biochemistry</italic> Vol. 52 (ed Derek Horton) 44–177 (Academic Press, 1997).</mixed-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="data">
        <name>
          <surname>Dashti</surname>
          <given-names>H</given-names>
        </name>
        <etal/>
        <year>2020</year>
        <data-title>Probabilistic identification of saccharide moieties in biomolecules and their protein complexes</data-title>
        <source>Open Science Framework</source>
        <pub-id pub-id-type="doi">10.17605/OSF.IO/Y4U8M</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
